XSNX

NovAccess Global Inc. [XSNX] Stock Forecast

Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000

XSNX Stock Summary

Top 10 Correlated Stocks

XSNX

In the News

XSNX Financial details

Company Rating
-
Market Cap
283.65K
Income
-789.95K
Revenue
0
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
3
Optionable
No
Shortable
Yes
Earnings
09 May 2024
P/E
-0.4
Forward P/E
-
PEG
0.02
P/S
-
P/B
-0.07
P/C
-
P/FCF
-0.66
Quick Ratio
0.02
Current Ratio
0.03
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-0.04
EPS next Y
-
EPS next Q
-
EPS this Y
-742.46%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
NAN%
Revenue last 5Y
-100%
Revenue Q/Q
-
EPS Q/Q
-168.63%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
-
Inst Trans
-
ROA
-615%
ROE
18%
ROC
0.38%
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
0.0081-0.22
52W High
-
52W Low
-
RSI
45.45
Rel Volume
-
Avg Volume
355.07K
Volume
Perf Week
0%
Perf Month
0%
Perf Quarter
-92.5%
Perf Half Y
-95.83%
-
-
-
-
Beta
1.458
-
-
Volatility
0%, 0%
Prev Close
0%
Price
0.0003
Change
0%

Something similar

Top by Market Cap
APC.DE
JPM
VOO
ABEA.DE
BRH.DE
Same Sector
4151.T
1345.HK
MANGALAM.NS
GTHP
PLX
Top Correlated Stocks
CEN.NZ
MEL.NZ
PKTX
CLVR
025620.KS
Similar Market Cap
HTCF.L
DDP
DTRK
CMCAW
3BPE.L

Company Profile

Healthcare Biotechnology
  • Volume Average 355.07K
  • Market Capitalization 283.65K
  • Employee 3
  • CEO Dr. Dwain K. Morris-Irvin M.P.H., MPH, Ph.D.
  • Headquarters Chesterland,OH,US
  • IPO Date 1998-09-21
  • Website https://novaccessglobal.com

NovAccess Global Inc., a biopharmaceutical company, develops novel immunotherapies to treat brain tumor patients in the United States. The company specializes in cutting-edge research related to utilizing a patient's immune system to attack the cancer. NovAccess Global Inc. was incorporated in 1997 and is headquartered in Chesterland, Ohio.